Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Short Term Effects of Pulmonary Rehabilitation on Level of Physical Activity and Self-Efficacy in Patients With Chronic Obstructive Pulmonary Disease.
The purpose of this study is to investigate whether pulmonary rehabilitation (PR) is
effective in increasing level of (a) physical activity (PA) and (b) self-efficacy in
patients with chronic obstructive pulmonary disease (COPD).
PR is an evidence-based multidisciplinary approach consisting primarily of a supervised
exercise program with educational components. It has demonstrated high efficacy in improving
dyspnoea, health-related quality of life (HRQoL) and functional exercise capacity in
patients with COPD. Despite these improvements, there is no conclusive evidence that these
benefits translate to an increase in PA in patient's day-to-day life. This is of concern as
low PA is a predictor of all cause mortality, correlated with lower HRQoL, increased level
of dyspnoea and higher number of hospital admissions in this group of patients.
Self-efficacy is found to be an instigating force in forming intention to exercise and in
maintaining practice for an extended time. Self-efficacy may be the key in determining
whether a patient translates the improvement in exercise tolerance to actually being more
physically active. Based on current knowledge, there is insufficient evidence that
self-efficacy increases after pulmonary rehabilitation and no correlation has been made
between level of self-efficacy and level of PA in these group of patients.
Hence this study aims to find out whether the existing PR program increases level of PA and
self-efficacy. Correlation between level of PA and self-efficacy will be made.
The intervention group will consist of all patients with chronic obstructive pulmonary
disease (COPD) referred to Guy's and St Thomas' Hospital (GSTT) pulmonary rehabilitation. A
sample of 30 is anticipated as this is the maximum number of patients who could be enrolled
in the 3 month recruitment period in Guy's and St. Thomas' Hospital.
1. The patient information sheet, together with the referral for PR, will be posted to the
patients. Patients will be informed about the study details in the patient information
sheet. This will include the fact that they have to wear an accelerometer for 5 to 7
days prior to starting the program. These accelerometers will be collected thereafter.
Instructions on the use of the accelerometers will be given. They will also be informed
that any personal information will strictly be kept confidential and that the results
will be used for analysis in the study.
2. Written consent will be taken on initial assessment if patient agrees to participate in
the study.
3. The Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) questionnaire will
be administered. It consists of 15 questions and will take less than 10 minutes to
complete.
4. The patient will undertake 14 sessions of PR under supervision to successfully complete
the program. The program is held at Guy's and St Thomas' Hospital.
5. The PRAISE questionnaire will be administered again after completion of the program.
Patients will be asked to wear the accelerometers again to track their physical
activity. After 5 to 7 days of use, the accelerometers will be collected either from
their address or via stamped postage.
No changes will be made to the current pulmonary rehabilitation program.
No control group is present in the study as pulmonary rehabilitation is the standard of care
and it is not ethical to withhold pulmonary rehabilitation from patients with COPD.
The null hypothesis would be that there is no difference in physical activity and
self-efficacy before and after pulmonary rehabilitation. The statistical test used will be a
paired sample t-test to determine the change in a) physical activity and b)self-efficacy
after pulmonary rehabilitation.
Correlation analysis will be made between self-efficacy and physical activity with a)
Anxiety and depression (Hospital anxiety and depression scale), b)Functional exercise
capacity (6 minute walk test) and c) COPD Assessment test.
A Pearson or Spearman correlations will be done depending on whether or not the data is
normally distributed.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|